GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$69.85 USD
-1.47 (-2.06%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $70.07 +0.22 (0.31%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
GEHC 69.85 -1.47(-2.06%)
Will GEHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GEHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GEHC
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
GEHC vs. BSX: Which Stock Is the Better Value Option?
GEHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
Other News for GEHC
GEHC: Morgan Stanley Maintains Equal-Weight, Lowers Price Target | GEHC Stock News
GEHC: Citigroup Maintains Buy Rating, Raises Price Target to $93 | GEHC Stock News
GE HealthCare price target raised by $6 at Citi, here's why
GEHC: Citi Boosts Price Target Amid Robust Pipeline
GE HealthCare price target raised by $4 at Citi, here's why